BSECompany Update2d ago · 26 Jul 2026, 09:12 pm
Intimation about publication of newspaper advertisement- Extract of unaudited Standalone and Consolidated financial results for the quarter ended June 30, 2026.
Onesource Specialty Pharma Ltd · 544292
✦ AI SummaryResults
Onesource Specialty Pharma Ltd has announced the publication of unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
11d50078-36cf-4eaa-a6cd-1d52d8deb635.pdf
View document text
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi,
560076, India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
F: +91 22 2789 2942
Date: July 26, 2026
BSE Limited National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G,
Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Bandra (E),
Scrip Code: 544292 Mumbai – 400 051
Symbol: ONESOURCE
Dear Sir/Madam,
Subject: Newspaper Advertisement: Un-audited Financial Results for the quarter ended June 30, 2026
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please
find enclosed herewith the copies of newspaper advertisement published on July 26, 2026 in the ‘Financial Express’ and
‘Lokmat’, providing extract of the Un-Audited Financial Results of the Company for the quarter ended June 30, 2026.
This is for your information and records.
For OneSource Specialty Pharma Limited
Trisha A
Company Secretary and Compliance Officer
Membership Number: A47635
OneSource Specialty Pharma Limited
Formerly Stelis Biopharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497